240 related articles for article (PubMed ID: 8718595)
1. Clinical trials of Shigella vaccines in Israel.
Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
[No Abstract] [Full Text] [Related]
2. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
Cohen D; Green MS; Block C; Rouach T; Ofek I
J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
[No Abstract] [Full Text] [Related]
3. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
4. Future needs and directions for Shigella vaccines.
Wkly Epidemiol Rec; 2006 Feb; 81(6):51-8. PubMed ID: 16673461
[No Abstract] [Full Text] [Related]
5. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
[No Abstract] [Full Text] [Related]
7. Prospective cohort studies of shigellosis during military field training.
Cohen D; Sela T; Slepon R; Yavzori M; Ambar R; Orr N; Robin G; Shpielberg O; Eldad A; Green M
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):123-6. PubMed ID: 11305466
[TBL] [Abstract][Full Text] [Related]
8. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
9. Shigella Sonnei vaccine.
Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
[No Abstract] [Full Text] [Related]
10. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
11. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
Prokopowicz D
Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
[No Abstract] [Full Text] [Related]
12. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
[TBL] [Abstract][Full Text] [Related]
13. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
[TBL] [Abstract][Full Text] [Related]
14. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB
Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
[No Abstract] [Full Text] [Related]
16. [Humoral and cellular immunity in patients with acute dysentery].
Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
[No Abstract] [Full Text] [Related]
17. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
[No Abstract] [Full Text] [Related]
18. [Parenteral use of a therapeutic vaccine in acute dysentery].
Ermakova ZF
Sov Med; 1979 May; (5):83-6. PubMed ID: 377515
[No Abstract] [Full Text] [Related]
19. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
20. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
[Next] [New Search]